|
SLC36A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62492241884138E-12 |
| Normal-vs-Stage2 |
3.790300E-04 |
| Normal-vs-Stage3 |
7.90100207481714E-11 |
| Normal-vs-Stage4 |
6.04060002018514E-09 |
| Stage1-vs-Stage2 |
2.853800E-01 |
| Stage1-vs-Stage3 |
4.596000E-01 |
| Stage1-vs-Stage4 |
3.866400E-01 |
| Stage2-vs-Stage3 |
4.805400E-01 |
| Stage2-vs-Stage4 |
5.584600E-01 |
| Stage3-vs-Stage4 |
8.570000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.21179999999799E-05 |
| Normal-vs-Asian |
5.244100E-02 |
| Caucasian-vs-AfricanAmerican |
5.539000E-01 |
| Caucasian-vs-Asian |
9.771400E-01 |
| AfricanAmerican-vs-Asian |
8.363000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.02140518265514E-14 |
| Male-vs-Female |
3.594200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.913820E-02 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6858736628933E-12 |
| Normal-vs-Age(81-100Yrs) |
6.083400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.290000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.386600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.434800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.291000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.755200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.704970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.264300E-02 |
| Normal-vs-Grade 2 |
2.88240542545282E-11 |
| Normal-vs-Grade 3 |
1.11022302462516E-16 |
| Normal-vs-Grade 4 |
5.19410003896326E-09 |
| Grade 1-vs-Grade 2 |
2.727200E-01 |
| Grade 1-vs-Grade 3 |
5.895000E-01 |
| Grade 1-vs-Grade 4 |
4.890400E-01 |
| Grade 2-vs-Grade 3 |
1.226250E-02 |
| Grade 2-vs-Grade 4 |
9.286300E-02 |
| Grade 3-vs-Grade 4 |
7.915800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.19260001874011E-09 |
| ccA subtype-vs-ccB subtype |
2.837000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.10702591327572E-15 |
| Normal-vs-N1 |
1.273520E-02 |
| N0-vs-N1 |
3.237600E-01 |
|
|
